Bill Text: IL HB0342 | 2019-2020 | 101st General Assembly | Introduced
Bill Title: Amends the Department of Public Health Powers and Duties Law of the Civil Administrative Code of Illinois. Requires the Department of Public Health to create and maintain a list of each immunizing agent derived from aborted fetal tissue and any alternative immunizing agents. Provides that the Department shall ensure that, before administering an immunizing agent derived from aborted fetal tissue to an individual, a health care provider shall provide to the individual or, if the individual is a child, to the parent, guardian, or person in loco parentis of the child: (1) notification that the immunizing agent was derived from aborted fetal tissue; (2) if an immunizing agent that is not an immunizing agent derived from aborted fetal tissue is available as an alternative to an immunizing agent derived from aborted fetal tissue, an offer of the alternative; and (3) notification of the option to decline the receipt of the immunizing agent. Effective immediately.
Spectrum: Partisan Bill (Republican 3-0)
Status: (Introduced - Dead) 2019-11-08 - Added Chief Co-Sponsor Rep. Brad Halbrook [HB0342 Detail]
Download: Illinois-2019-HB0342-Introduced.html
| |||||||||||||||||||||||||
| |||||||||||||||||||||||||
| |||||||||||||||||||||||||
| |||||||||||||||||||||||||
| |||||||||||||||||||||||||
| 1 | AN ACT concerning health.
| ||||||||||||||||||||||||
| 2 | Be it enacted by the People of the State of Illinois,
| ||||||||||||||||||||||||
| 3 | represented in the General Assembly:
| ||||||||||||||||||||||||
| 4 | Section 5. The Department of Public Health Powers and | ||||||||||||||||||||||||
| 5 | Duties Law of the
Civil Administrative Code of Illinois is | ||||||||||||||||||||||||
| 6 | amended by adding Section 2310-578 as follows:
| ||||||||||||||||||||||||
| 7 | (20 ILCS 2310/2310-578 new) | ||||||||||||||||||||||||
| 8 | Sec. 2310-578. Immunizing agents derived from aborted | ||||||||||||||||||||||||
| 9 | fetal tissue. | ||||||||||||||||||||||||
| 10 | (a) As used in this Section: | ||||||||||||||||||||||||
| 11 | (1) "Health care provider" means any physician, | ||||||||||||||||||||||||
| 12 | advanced practice registered nurse, physician assistant, | ||||||||||||||||||||||||
| 13 | hospital facility, or other person that is licensed or | ||||||||||||||||||||||||
| 14 | otherwise authorized to deliver health care services. | ||||||||||||||||||||||||
| 15 | (2) "Immunizing agent derived from aborted fetal | ||||||||||||||||||||||||
| 16 | tissue" means
an immunizing agent that is manufactured | ||||||||||||||||||||||||
| 17 | using a human fetal or
embryonic cell line, protein, | ||||||||||||||||||||||||
| 18 | deoxyribonucleic acid, recombinant
deoxyribonucleic acid, | ||||||||||||||||||||||||
| 19 | monoclonal antibody, or any other component
derived from an | ||||||||||||||||||||||||
| 20 | elective abortion or using a cell line derived from
the | ||||||||||||||||||||||||
| 21 | tissue of a fetus that was electively aborted. | ||||||||||||||||||||||||
| 22 | (b) The Department shall create and maintain a
list of each | ||||||||||||||||||||||||
| 23 | immunizing agent derived from aborted fetal tissue. If
an | ||||||||||||||||||||||||
| |||||||
| |||||||
| 1 | immunizing agent that is not an immunizing agent derived from
| ||||||
| 2 | aborted fetal tissue is available as an alternative to an
| ||||||
| 3 | immunizing agent derived from aborted fetal tissue, the | ||||||
| 4 | Department
shall include the alternative on the list. The | ||||||
| 5 | Department shall
update the list annually and make the list | ||||||
| 6 | available to the public
on the Department's website. | ||||||
| 7 | (c) The Department shall ensure that, beginning January 1, | ||||||
| 8 | 2020, before administering an immunizing agent derived from | ||||||
| 9 | aborted fetal tissue to an individual, a health care provider | ||||||
| 10 | shall notify the individual or, if the individual is a child, | ||||||
| 11 | the parent, guardian, or person in loco parentis of the child | ||||||
| 12 | that the immunizing agent was derived from aborted fetal | ||||||
| 13 | tissue. If an immunizing agent that is not an immunizing agent | ||||||
| 14 | derived from aborted fetal tissue is available as an | ||||||
| 15 | alternative to an immunizing agent derived from aborted fetal | ||||||
| 16 | tissue, the health care provider shall offer the alternative to | ||||||
| 17 | the individual or, if the individual is a child, to the parent, | ||||||
| 18 | guardian, or person in loco parentis of the child. A health | ||||||
| 19 | care provider shall also notify the individual or, if the | ||||||
| 20 | individual is a child, the parent, guardian, or person in loco | ||||||
| 21 | parentis of the child of the option to decline the receipt of | ||||||
| 22 | the immunizing agent.
| ||||||
| 23 | Section 99. Effective date. This Act takes effect upon | ||||||
| 24 | becoming law.
| ||||||
